Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2009 1
2010 1
2011 2
2012 2
2013 7
2014 2
2015 4
2016 4
2017 3
2018 1
2019 2
2020 2
2021 5
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C.
Martinez-Navajas G, Ceron-Hernandez J, Simon I, Lupiañez P, Diaz-McLynn S, Perales S, Modlich U, Guerrero JA, Martin F, Sevivas T, Lozano ML, Rivera J, Ramos-Mejia V, Tersteeg C, Real PJ. Martinez-Navajas G, et al. Among authors: simon i. Mol Ther Nucleic Acids. 2023 Jun 12;33:75-92. doi: 10.1016/j.omtn.2023.06.008. eCollection 2023 Sep 12. Mol Ther Nucleic Acids. 2023. PMID: 37416759 Free PMC article.
Generation of a H9 Clonal Cell Line With Inducible Expression of NUP98-KDM5A Fusion Gene in the AAVS1 Safe Harbor Locus.
Domingo-Reinés J, Martínez-Navajas G, Montes R, Lamolda M, Simón I, Castaño J, Ríos-Pelegrina R, Lopez-Hidalgo JL, García Del Moral R, Marchal JA, Real PJ, Ramos-Mejía V. Domingo-Reinés J, et al. Among authors: simon i. Front Cell Dev Biol. 2022 Jun 1;10:846092. doi: 10.3389/fcell.2022.846092. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35721502 Free PMC article.
Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer-A Europe-Wide External Quality Assessment.
Erber R, Hartmann A, Fasching PA, Ruebner M, Stöhr R, Beckmann MW, Zentgraf M, Popp V, Weidler J, Simon I, Becker S, Huebner H, Fischer J, Guerini Rocco E, Viale G, Cayre A, Penault-Llorca F, Caniego Casas T, Pérez-Miés B, Palacios J, Jank P, Denkert C, Khoury L, Mairinger T, Ferrazzi F. Erber R, et al. Among authors: simon i. Cancers (Basel). 2021 Sep 21;13(18):4718. doi: 10.3390/cancers13184718. Cancers (Basel). 2021. PMID: 34572945 Free PMC article.
Cross-Resistance to Abiraterone and Enzalutamide in Castration Resistance Prostate Cancer Cellular Models Is Mediated by AR Transcriptional Reactivation.
Simon I, Perales S, Casado-Medina L, Rodríguez-Martínez A, Garrido-Navas MDC, Puche-Sanz I, Diaz-Mochon JJ, Alaminos C, Lupiañez P, Lorente JA, Serrano MJ, Real PJ. Simon I, et al. Cancers (Basel). 2021 Mar 23;13(6):1483. doi: 10.3390/cancers13061483. Cancers (Basel). 2021. PMID: 33807106 Free PMC article.
Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert® Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer.
Cowan B, Klein E, Jansz K, Westenfelder K, Bradford T, Peterson C, Scherr D, Karsh LI, Egerdie B, Witjes A, Trainer A, Harris R, Goldfarb B, Flax S, Kroeger R, Boyd B, Liao J, Patel S, Bridge J, Reuter V, Quigley N, Brown S, Zhao S, Satya M, Bates M, Simon IM, Campbell S, Lotan Y. Cowan B, et al. Among authors: simon im. BJU Int. 2021 Dec;128(6):713-721. doi: 10.1111/bju.15418. Epub 2021 May 5. BJU Int. 2021. PMID: 33793062 Free PMC article.
Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria.
Valenberg FJPV, Hiar AM, Wallace E, Bridge JA, Mayne DJ, Beqaj S, Sexton WJ, Lotan Y, Weizer AZ, Jansz GK, Stenzl A, Danella JF, Cline KJ, Williams MB, Montgomery S, David RD, Harris R, Klein EW, Bradford TJ, Wolk FN, Westenfelder KR, Trainer AF, Richardson TA, Egerdie RB, Goldfarb B, Zadra JA, Lu X, Simon IM, Campbell SA, Bates MP, Higuchi RG, Witjes JA. Valenberg FJPV, et al. Among authors: simon im. Eur Urol Oncol. 2021 Feb;4(1):93-101. doi: 10.1016/j.euo.2020.09.001. Epub 2020 Sep 28. Eur Urol Oncol. 2021. PMID: 33004290 Free article.
GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant.
Lamolda M, Montes R, Simón I, Perales S, Martínez-Navajas G, Lopez-Onieva L, Ríos-Pelegrina R, Del Moral RG, Griñan-Lison C, Marchal JA, Lozano ML, Ramos-Mejia V, Rivera J, Bastida JM, Real PJ. Lamolda M, et al. Among authors: simon i. Stem Cell Res. 2019 Dec;41:101603. doi: 10.1016/j.scr.2019.101603. Epub 2019 Oct 15. Stem Cell Res. 2019. PMID: 31698193 Free article.
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer.
Valenberg FJPV, Hiar AM, Wallace E, Bridge JA, Mayne DJ, Beqaj S, Sexton WJ, Lotan Y, Weizer AZ, Jansz GK, Stenzl A, Danella JF, Shepard B, Cline KJ, Williams MB, Montgomery S, David RD, Harris R, Klein EW, Bradford TJ, Wolk FN, Westenfelder KR, Trainer AF, Richardson TA, Egerdie RB, Goldfarb B, Zadra JA, Ge S, Zhao S, Simon IM, Campbell SA, Rhees B, Bates MP, Higuchi RG, Witjes JA. Valenberg FJPV, et al. Among authors: simon im. Eur Urol. 2019 May;75(5):853-860. doi: 10.1016/j.eururo.2018.11.055. Epub 2018 Dec 12. Eur Urol. 2019. PMID: 30553612
35 results